Bnp Paribas Asset Management Holding S.A. Exact Sciences Corp Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Exact Sciences Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 17,012 shares of EXAS stock, worth $752,781. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,012
Previous 6,166
175.9%
Holding current value
$752,781
Previous $420,000
127.62%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding EXAS
# of Institutions
668Shares Held
152MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$776 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$753 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$534 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$276 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$255 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.83B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...